Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
Hours: Full time on site – 36 hours per week Contract type: Fixed Term - 23 months Nucleic Acid Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI
-
Applications are invited for a Postdoctoral Researcher to join an exciting Medical Research Council (MRC) funded project that focuses on increasing access to Cognitive Behavioural Therapy (CBT
-
programme of research, funded by the Medical Research Council (MRC) Biomedical Catalyst: Developmental Pathway Funding Scheme (DPFS). The successful candidate will develop and perform psychophysical
-
, heart disease, stroke, infections, and neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University
-
to prevent, diagnose and treat illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases. An independent organisation, its founding partners are the Medical Research Council
-
organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London. The Crick was formed
-
Institute / Unit Information 1 The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), has invested a total of £30M over 5 years to establish the Nucleic Acid Therapy Accelerator
-
, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King’s College London. The Crick was formed in
-
Threats & Hazards (CRTH ) at Imperial College London. You will play a central role in advancing the field of environmental epidemiology within the unit, which is closely linked to the Medical Research
-
-adrenal (HPA) axis, and how this changes under different conditions of stress. This Medical Research Council (MRC) funded post is available from 01 March 2024 - 30 September 2024. The successful applicant